VioQuest Pharmaceuticals, Inc. Names Vernon L. Alvarez, Ph.D. as Vice President, Research & Development and Announces Resignation of Chief Scientific Officer

BASKING RIDGE, N.J.--(BUSINESS WIRE)--VioQuest Pharmaceuticals (OTCBB: VQPH) today announced the appointment of Vernon L. Alvarez, Ph.D., as Vice President, Research and Development. Dr. Alvarez will report to Michael D. Becker, President and Chief Executive Officer of VioQuest Pharmaceuticals.
MORE ON THIS TOPIC